Comparative Analysis of HMC3 and C20 Microglial Cell Lines Reveals Differential Myeloid Characteristics and Responses to Immune Stimuli
Immunology · 2025-05 · 175 (1) · 84-102
DOI: 10.1111/imm.13900 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Immunology, online erschienen am 17.02.2025. Verfasst von Bavani Gunasegaran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Microglia, Myeloid Cells. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macquarie University Research Training Program Domestic Scholarship, Susie Myers Glioblastoma Scholarship, Macquarie University Research Training Program International Scholarship.
Abstract (Originalsprache)
Microglia are the primary resident immune cells of the central nervous system (CNS) that respond to injury and infections. Being critical to CNS homeostasis, microglia also have been shown to contribute to neurodegenerative diseases and brain cancer. Hence, microglia are regarded as a potential therapeutic target in CNS diseases, resulting in an increased demand for reliable in vitro models. Two human microglia cell lines (HMC3 and C20) are being used in multiple in vitro studies, however, the knowledge of their biological and immunological characteristics remains limited. Our aim was to identify and compare the biological changes in these immortalised immune cells under normal physiological and immunologically challenged conditions. Using high‐resolution quantitative mass spectrometry, we have examined in‐depth proteomic profiles of non‐stimulated and LPS or IFN‐γ challenged HMC3 and C20 cells. Our findings reveal that HMC3 cells responded to both treatments through upregulation of immune, metabolic, and antiviral pathways, while C20 cells showed a response associated with mitochondrial and immune activities. Additionally, the secretome analysis demonstrated that both cell lines release IL‐6 in response to LPS, while IFN‐γ treatment resulted in altered kynurenine pathway activity, highlighting distinct immune and metabolic adaptations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
- Computational Neurosurgery (CNS) Lab, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
ORCID-Profile: Bavani Gunasegaran, Anna Guller
Förderung
- Macquarie University Research Training Program Domestic Scholarship
- Susie Myers Glioblastoma Scholarship
- Macquarie University Research Training Program International Scholarship
- Macquarie University Research Fellowship
- Cancer Council NSW
Zitieren
APA
Gunasegaran, B., Krishnamurthy, S., Chow, S. S., Villanueva, M. D., Guller, A., Ahn, S. B., & Heng, B. (2025). Comparative Analysis of HMC3 and C20 Microglial Cell Lines Reveals Differential Myeloid Characteristics and Responses to Immune Stimuli. Immunology, 175(1), 84-102. https://doi.org/10.1111/imm.13900
Vancouver
Gunasegaran B, Krishnamurthy S, Chow SS, Villanueva MD, Guller A, Ahn SB, et al. Comparative Analysis of HMC3 and C20 Microglial Cell Lines Reveals Differential Myeloid Characteristics and Responses to Immune Stimuli. Immunology. 2025;175(1):84-102. doi:10.1111/imm.13900
BibTeX
@article{Gunasegaran2025,
author = {Gunasegaran, Bavani and Krishnamurthy, Shivani and Chow, Sharron S and Villanueva, Millijoy D and Guller, Anna and Ahn, Seong Beom and Heng, Benjamin},
title = {Comparative Analysis of HMC3 and C20 Microglial Cell Lines Reveals Differential Myeloid Characteristics and Responses to Immune Stimuli},
journal = {Immunology},
year = {2025},
volume = {175},
number = {1},
pages = {84--102},
doi = {10.1111/imm.13900}
}
EUVIMED